“…(9–21) Most estimates of prevalence of ACOS among a population of individuals with asthma appears to be slightly higher, with estimates ranging 27.1%–38%(13, 16, 18), whereas estimates of ACOS within a population of individuals with COPD appear to be slightly lower, ranging mostly from 13%–28.6%. (9–11, 14, 17, 19–21) Other than the differences in population characteristics which may account for the variation in prevalence estimates, the definitions utilized to identify individuals with ACOS also differ greatly. Several studies, particularly those in which the population studied is primarily composed of individuals with COPD, have defined ACOS as an individual with a spirometric diagnosis of COPD, most commonly employing Global Initiative of Chronic Obstructive Lung Disease (GOLD) criteria,(22) American Thoracic Society/European Respiratory Society (ATS/ERS) criteria,(23) or some slight variation of these criteria, and also reporting a diagnosis of asthma earlier in life, such as prior to the age of 40.…”